account_id none on file
legal_name NEUROONE MEDICAL TECHNOLOGIES Corp
ticker NMTC
cik 1500198
domain nmtc1.com
linkedin_company_url https://www.linkedin.com/company/n1mtc/
entry_point_account_id none on file
name NeuroOne Medical Technologies Corporation
exchange Nasdaq
sector Health Care
hq Eden Prairie, MN, United States
sector index/company/sector/health-care/
calls 0 filings 8 executives 1 family 0
why_nownone on file
callsnone on file
filings
We recently appointed a new Chief Financial Officer, and while we believe this individual is well qualified, leadership transitions can create uncertainties, disrupt operational processes, and require significant management attention.
filing / Aug 13, 2026 / receipt
On May 20, 2024, the Company amended its non-cancellable headquarters lease (the “Lease”) with certain landlords (together, the “Landlord”) pursuant to which the Company leases office space located at 7599 Anagram Drive, Eden Prairie, Minnesota (the “Premises”).
filing / Aug 13, 2026 / receipt
In 2021, the Company entered into and commenced a non-cancellable facility lease (the “Los Gatos Lease”), pursuant to which the Company agreed to rent office space for its research and development operations located at 718 University Avenue, Suite #111, Los Gatos, California.
filing / Aug 13, 2026 / receipt
If the transition is not successfully managed, or if we are unable to effectively integrate the new Chief Financial Officer into our operations, our financial performance, internal control environment, investor confidence, and stock price could be adversely affected.
filing / Aug 13, 2026 / receipt
leases office space located at 7599 Anagram Drive, Eden Prairie, Minnesota (the “Premises”). The Company took possession of
filing / May 12, 2026 / receipt
a non-cancellable facility lease (the “Los Gatos Lease”), pursuant to which the Company agreed to rent office space for its
filing / May 12, 2026 / receipt
FY26 product revenue expected to increase to at least $10.5 million representing at least 15% annual growth
ir_statement / Sep 15, 2026 / receipt
Expanding in US and preparing to commercialize in select OUS countries
ir_statement / Sep 15, 2026 / receipt
executives
| Christopher R. Volker | Chief Operating Officer | receipt |
familynone on file
upcomingnone on file
changes
| 2023-11-14 | Chief Operating Officer, appointed | sec_8k |
mcp_package_hint
slug neuroone-medical-technologies-corporation
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$